Investor Presentaiton
BIOMINAS INVESTMENT UNIT CASES
Prodimol
BIOTECNOLOGIA"
UMA EMPRESA DO GRUPO
inverness medical
-Created in 2003 after the acquisition of Biobras by Novo Nordisk (DK) (former
diagnostic unit of Biobras)
- Received investment from Biominas and FIR Capital in 2003
- Development of a business plan by Biominas in 2004
- Reached sales of US$ 12 million in 2007
- Sold to Inverness Medical Group (USA) in 2009
Return on Investment. MULTIPLE 4 X
- Created and invested in 2003 by Biominas and FIR Capital
-Licensed technology from FIOCRUZ to develop human and animal vaccines in
2005
- Received grants from FINEP of US$ 3 million in 2006
- Established out-licensing agreement with Ourofino (BR) to the animal vaccine
in 2007
- Sold to Ourofino (BR) in 2010
- Return on Investment. MULTIPLE 2,5 X
alvos
www.biominas.org.brView entire presentation